Griseofulvin

灰黄霉素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGriseofulvin
Drug Alias Name灰霉素Griseofulvina灰荑霉素Griseofulvinum灰黄霉荤 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsDermatomycosesMycoses
Global Approved IndicationsDermatomycoses
Approved Indications in ChinaDermatomycoses
Original Approved Country/TerritoryUnited States
Original Approved Date1962/08/22
Country/TerritoryCanadaUnited StatesIndia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Huajin Pharmaceutcial Co LtdHuazhong Pharmaceutical Co LtdYouhua Pharmaceutical (Leshan) Co Ltd +[6] 
Inactive CompaniesGlaxosmithkline PlcActavis IncWyeth-Ayerst +[4] 
Active IndicationsDermatomycoses
Inactive IndicationsMycoses

Other Information

ATC CodeD01AA08D01BA01
Related LinksWikipediaDrugBankKEGG